Liber Pharmaceuticals’ statement on ingredient safety and device design of its Nicovape Q products
Pharmacy Practice Notice Published on 10 March 2026 Liber Pharmaceuticals’ statement on ingredient...
Modules
Our features, journey, tips and us being us. Lorem ipsum dolor sit amet, accumsan in, tempor dictum neque.
Pharmacy practice notice: Transition to Nicovape® Q2 System Complete
Pharmacy Practice Notice Published on 9 January 2025 Transition to Nicovape® Q2 System...
The regulatory framework governing therapeutic vapes
Prescriber Information Hub The regulatory framework governing therapeutic vapes Since 2021, vapes may...
The scientific consensus on vaping
Pharmacist Information Hub The scientific consensus on vaping The gold standard for understanding...
Understanding the current vaping laws
Prescriber Information Hub Understanding the current vaping laws GPs have prescribed vaping products...
Pharmacy practice notice: Scheduling of NVPs in Western Australia
Pharmacy Practice Notice Published on 22 November 2024 Scheduling of NVPs in Western...
Understanding the current vaping laws
Pharmacist Information Hub Understanding the current vaping laws Pharmacists have dispensed vaping products...
The scientific consensus on vaping
Pharmacist Information Hub The scientific consensus on vaping The gold standard for understanding...
The role of therapeutic vaping in pharmacy
Pharmacist Information Hub The role of therapeutic vaping in pharmacy Pharmacists are the...